Cancer Vaccine to Be Tested in Lymphoma Patients

By Nick Tate – Re-Blogged From Newsmax Health

Stanford Univesity researchers are recruiting lymphoma patients to test a new cancer vaccine that had a 97 percent success rate in “curing” mice with cancer.

The clinical trial will involve about 15 patients with low-grade lymphoma and begin by the end of the year, according to a Stanford news release.

 Lead research Dr. Ronald Levy, director of the lymphoma program at the Stanford Cancer Institute in California, said he believes the treatment could be useful for many tumor types.

Continue reading

Advertisements